WB: 1:500-1:3000, IHC-P: 1:100-1:1000 [suggested antigen retrieval using heat mediated 10 mM Citrate buffer ( pH 6.0) or Tris-EDTA buffer ( pH 8.0)], ICC/IF: 1:100-1:1000, ChIP. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.
Restrictions
For Research Use only
Format
Liquid
Concentration
0.22 mg/mL
Buffer
PBS
Storage
-20 °C
Storage Comment
Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
Li, Lin, Deng, Strnad, Bernabei, Vogl, Burke, Nefedova: "A Novel Peptidylarginine Deiminase 4 (PAD4) Inhibitor BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma." in: Molecular cancer therapeutics, Vol. 19, Issue 7, pp. 1530-1538, (2020) (PubMed).
Target
PAD4 (PADI4)
(Peptidyl Arginine Deiminase, Type IV (PADI4))